Asio Capital LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 26,577 shares of the healthcare conglomerate’s stock after purchasing an additional 2,344 shares during the quarter. UnitedHealth Group comprises about 1.2% of Asio Capital LLC’s holdings, making the stock its 20th biggest holding. Asio Capital LLC’s holdings in UnitedHealth Group were worth $8,773,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in UNH. Guerra Advisors Inc purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $1,059,000. Berkshire Hathaway Inc purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $1,572,193,000. Carnegie Investment Counsel increased its position in UnitedHealth Group by 2.2% during the third quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock valued at $36,471,000 after acquiring an additional 2,316 shares during the last quarter. Phoenix Financial Ltd. boosted its position in UnitedHealth Group by 111.5% in the third quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after purchasing an additional 22,137 shares during the last quarter. Finally, Money Concepts Capital Corp increased its position in shares of UnitedHealth Group by 59.1% during the 3rd quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate’s stock valued at $4,275,000 after purchasing an additional 4,600 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
UNH has been the subject of a number of research reports. Leerink Partners reduced their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Jefferies Financial Group lowered their target price on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Evercore raised UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings lowered shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $363.42.
Trending Headlines about UnitedHealth Group
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: CMS finalized a larger-than-expected 2027 Medicare Advantage payment increase (net average +2.48%), meaningfully above January’s proposal and street expectations — the decision injects roughly $13B+ into the MA program and is the main catalyst for today’s rally. Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
- Positive Sentiment: Brokerages moved to capitalize on the policy tailwind: Sanford C. Bernstein and others raised price targets and ratings, and Bank of America boosted its PT — analyst upward revisions help sustain the rally by signaling higher modeled earnings and margin recovery. Sanford C. Bernstein price target update
- Positive Sentiment: Sector-wide lift — other insurers (Humana, Centene, Oscar Health) rose on the same CMS decision, reinforcing that UnitedHealth benefits from industry-level tailwinds (scale and MA exposure). UnitedHealth and other insurer stocks jump after Medicare agrees to lift payments next year
- Neutral Sentiment: Macro/market context is mixed — broader US indexes showed mixed action Tuesday (oil lower, geopolitics impacting sentiment), so some of UNH’s move is idiosyncratic to healthcare rather than a broad market rally. US Equity Markets Mixed Amid Lower Crude Oil Price, Diminishing Hopes of Iran Ceasefire Deal
- Negative Sentiment: Risks remain — elevated medical cost pressures, previous guidance weakness and an upcoming Q1 report (April 21) could reintroduce volatility if results or forward commentary disappoint; the policy boost reduces but does not eliminate these operational risks. UnitedHealth Q1 Earnings Preview
UnitedHealth Group Trading Up 9.3%
UnitedHealth Group stock opened at $307.55 on Wednesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The firm’s 50 day moving average price is $282.12 and its 200-day moving average price is $319.04. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a market cap of $279.16 billion, a P/E ratio of 23.32, a PEG ratio of 1.28 and a beta of 0.40.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the firm posted $6.81 EPS. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
